Available chemical structures for SERT inhibitors

vilazodone
Click here for ligand page
Targets
5-HT1A receptor; 5-HT4 receptor; D2 receptor; D3 receptor; H1 receptor; SERT
escitalopram
Click here for ligand page
Targets
SERT
dapoxetine
Click here for ligand page
Targets
SERT
venlafaxine
Click here for ligand page
Targets
NET; SERT
milnacipran
Click here for ligand page
Targets
NET; SERT
levomilnacipran
Click here for ligand page
Targets
DAT; NET; SERT
ibogaine
Click here for ligand page
Targets
SERT
toludesvenlafaxine
Click here for ligand page
Targets
DAT; NET; SERT
norzotepine
Click here for ligand page
Targets
NET; SERT
zotepine
Click here for ligand page
Targets
α2B-adrenoceptor; 5-HT1A receptor; 5-HT1B receptor; 5-HT1D receptor; 5-HT2A receptor; 5-HT2C receptor; 5-HT6 receptor; 5-HT7 receptor; D2 receptor; D3 receptor; D4 receptor; H1 receptor; NET
paroxetine
Click here for ligand page
Targets
P2X4; SERT
[3H]paroxetine
Click here for ligand page
Targets
SERT
clomipramine
Click here for ligand page
Targets
α1A-adrenoceptor; DAT; Kir3.2; Kir3.4; NET; SERT
fluvoxamine
Click here for ligand page
Targets
SERT; sigma non-opioid intracellular receptor 1
[3H]citalopram
Click here for ligand page
Targets
SERT
atomoxetine
Click here for ligand page
Targets
DAT; NET; SERT
protriptyline
Click here for ligand page
Targets
NET; SERT
nefazodone
Click here for ligand page
Targets
5-HT2A receptor; CYP3A4; NET; SERT
sertraline
Click here for ligand page
Targets
SERT
vortioxetine
Click here for ligand page
Targets
5-HT1A receptor; 5-HT1B receptor; 5-HT1D receptor; 5-HT3AB; 5-HT5A receptor; 5-HT6 receptor; 5-HT7 receptor; SERT
fluoxetine
Click here for ligand page
Targets
5-HT2A receptor; 5-HT2B receptor; 5-HT2C receptor; 5-HT6 receptor; CaCC; Kv3.1; Kir3.2; Plasma membrane monoamine transporter; SERT
citalopram
Click here for ligand page
Targets
NET; SERT
H05
Click here for ligand page
Targets
5-HT2A receptor; NET; SERT
duloxetine
Click here for ligand page
Targets
5-HT2A receptor; 5-HT2C receptor; 5-HT6 receptor; NET; SERT; zinc finger CCCH-type containing 14
nortriptyline
Click here for ligand page
Targets
α1A-adrenoceptor; Kir3.2; Kir3.4; Kir4.1; NET; SERT
dosulepin
Click here for ligand page
Targets
H1 receptor; M1 receptor; M2 receptor; M3 receptor; M4 receptor; M5 receptor; NET; SERT
desvenlafaxine
Click here for ligand page
Targets
DAT; NET; SERT
amoxapine
Click here for ligand page
Targets
5-HT2A receptor; 5-HT2C receptor; 5-HT6 receptor; 5-HT7 receptor; NET; SERT
desipramine
Click here for ligand page
Targets
Kir3.2; Kir3.4; NET; Organic cation transporter 1; Plasma membrane monoamine transporter; SERT
imipramine
Click here for ligand page
Targets
Kv10.1; Kir3.2; Kir3.4; M2 receptor; NET; SERT
ziprasidone
Click here for ligand page
Targets
5-HT1A receptor; 5-HT1B receptor; 5-HT1D receptor; 5-HT2A receptor; 5-HT2C receptor; 5-HT7 receptor; 5-ht1e receptor; D2 receptor; H1 receptor; NET; SERT
lofepramine
Click here for ligand page
Targets
NET; SERT
lumateperone
Click here for ligand page
Targets
5-HT2A receptor; D2 receptor; SERT
doxepin
Click here for ligand page
Targets
H1 receptor; NET; SERT
amitriptyline
Click here for ligand page
Targets
α1A-adrenoceptor; 5-HT2A receptor; 5-HT2C receptor; 5-HT6 receptor; 5-HT7 receptor; H1 receptor; M1 receptor; M2 receptor; M3 receptor; M4 receptor; M5 receptor; NET; SERT
trimipramine
Click here for ligand page
Targets
DAT; NET; SERT
sibutramine
Click here for ligand page
Targets
CYP2B6; DAT; Kv4.3; NET; SERT
phenelzine
Click here for ligand page
Targets
CYP2C8; DAT; Monoamine oxidase A; Monoamine oxidase B; NET; SERT; amine oxidase copper containing 3

Please note that chemical structures may not be available for all inhibitors at this target. For more details please email us.